Analyst firms · BofA Securities · SAGE
BofA Securities SAGE price target and rating history
Sage Therapeutics Inc. (SAGE) · Health Care
BofA Securities rates Sage Therapeutics Inc. (SAGE) Underperform with a $5 price target, as of its latest action on Mar 11, 2025. It has published 3 rating actions on SAGE since August 2023, including 0 upgrades and 2 downgrades.
- Current rating
- Underperform
- Price target
- $5
- Median target, all firms
- Too few
- Actions on SAGE
- 3
BofA Securities price target on SAGE
Every BofA Securities rating on SAGE
- Mar 11, 2025
- Apr 17, 2024
- Aug 7, 2023
Questions about BofA Securities and SAGE
- What is BofA Securities's price target for SAGE?
- BofA Securities's latest stated price target for Sage Therapeutics Inc. (SAGE) is $5, from its action on Mar 11, 2025.
- What is BofA Securities's rating on SAGE?
- BofA Securities rates SAGE Underperform, a bearish rating, as of Mar 11, 2025.
- When did BofA Securities last change its view on SAGE?
- On Mar 11, 2025, BofA Securities resumes coverage at Underperform, price target $5.
More SAGE rating histories
All BofA Securities ratingsSAGE news and filingsEvery analyst firm
From rating actions in the Quantisnow feed. A target holds until the firm states a new one; a reiteration with no target keeps the last one. Not investment advice.